0

Pharmaceutical company Pfizer announced on Thursday that its vaccine for the respiratory syncytial virus, or RSV, has begun the third phase of its clinical trials among adults, which comes almost two weeks after the Food Drug Administration (FDA) has fully authorized Pfizer's SARS-CoV-2 or COVID-19 vaccine.

Source


Like it? Share with your friends!

0

What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
0
fail
fun fun
0
fun
geeky geeky
0
geeky
love love
0
love
lol lol
0
lol
omg omg
0
omg
win win
0
win
admin

0 Comments

Your email address will not be published. Required fields are marked *